News from QIAGEN N.V. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 15, 2017, 16:05 ET QIAGEN Advances Precision Medicine by Automating Guidelines on Cancer Variants in Industry-leading QIAGEN Clinical Insight Software

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software...


Nov 14, 2017, 16:17 ET QIAGEN's GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology

QIAGEN N.V. (NASDAQ: QGEN) (Frankfurt Prime Standard: QIA) today announced new studies highlighting the outstanding analytical performance and...


Nov 13, 2017, 16:02 ET QIAGEN Celebrates Surpassing 2,000 Cumulative Placements of QIAsymphony

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,000th placement of QIAsymphony, the leading Sample to Insight...


Nov 06, 2017, 16:05 ET QIAGEN Reports Results for Third Quarter and First Nine Months of 2017

- Solid Q3 2017 performance in line with full-year ambitions: - Net sales $364.0 million (+7% actual, +7% CER); adjusted net sales...


Oct 24, 2017, 11:25 ET QIAGEN and ICMP Launch Next-Generation DNA Testing Solutions for Identifying Missing Persons

The International Commission on Missing Persons (ICMP) today announced the launch of a cutting-edge next-generation sequencing (NGS) workflow...


Oct 19, 2017, 16:36 ET QIAGEN Announces High Accuracy of Bioinformatics Solutions in Women's Health Genetic Screening

QIAGEN (NASDAQ: QGEN; Frankfurt Stock Exchange: QIA) today announced the results of a study evaluating the accuracy of the QIAGEN Clinical Insight...


Oct 16, 2017, 06:20 ET QIAGEN N.V. to Report Third Quarter and First Nine Months of 2017 Results

QIAGEN N.V. (NASDAQ: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the third quarter and first nine...


Oct 12, 2017, 16:05 ET QIAGEN Bioinformatics and NGS Solutions Enable Genomic Breakthroughs

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its Sample to Insight solutions, from next-generation sequencing...


Oct 09, 2017, 16:05 ET QIAGEN and CENTOGENE to Collaborate in Bioinformatics for Genetic Diseases

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and CENTOGENE AG today announced a collaboration and co-marketing agreement to provide...


Oct 05, 2017, 16:05 ET QIAGEN Launches Fourth-generation QuantiFERON®-TB Gold Plus in the U.S.

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of QuantiFERON®-TB Gold Plus (QFT®-Plus), the fourth...


Oct 02, 2017, 16:05 ET QIAGEN Achieves ISO Certification for State-of-the-art Quality in Forensics

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its manufacturing and supply chain for consumables and other products...


Aug 21, 2017, 16:05 ET QIAGEN and Clinical Genomics Partner on Liquid Biopsies to Monitor Patients for Recurrence of Colorectal Cancer

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and Clinical Genomics, a private company developing evidence-based diagnostic tools for...


Jul 27, 2017, 11:16 ET QIAGEN Reports Results for Second Quarter and First Half of 2017

- Strong Q2 2017 results reaffirm QIAGEN on track to achieve full-year goals: - Net sales $349.0 million (+4% actual); adjusted net...


Jul 13, 2017, 04:02 ET QIAGEN N.V. to Report Second Quarter and First Half of 2017 Results

QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the second quarter and first half of...


Jun 22, 2017, 08:04 ET French health system approves reimbursement of QIAGEN's QuantiFERON latent TB test

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that France's Ministry of Health and Social Affairs has approved...


Jun 22, 2017, 08:00 ET Approbation par le système d’assurance maladie français du remboursement de QuantiFERON, le test de dépistage de l’infection tuberculeuse latente de QIAGEN

Le test de choix pour le dépistage de la tuberculose latente sera remboursé par l'assurance maladie nationale QIAGEN N.V. (NASDAQ : QGEN ;...


Jun 08, 2017, 09:00 ET QIAGEN's QuantiFERON®-TB Gold Plus gains U.S. FDA approval

QIAGEN N.V. (NASDAQ: QGEN) (Frankfurt Prime Standard: QIA) today announced the U.S. regulatory approval of QuantiFERON®-TB Gold Plus (QFT®-Plus)...


Jun 06, 2017, 02:00 ET QIAGEN receives U.S. FDA approval for cytomegalovirus (CMV) testing on automated QIAsymphony platform

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received premarket approval from the U.S. Food and Drug...


Jun 03, 2017, 13:00 ET QIAGEN expands biomarker content portfolio to support greater use of molecular diagnostics for immuno-oncology therapies

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for...


Jun 03, 2017, 13:00 ET Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies

Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of...


May 02, 2017, 16:05 ET QIAGEN Reports Results for First Quarter 2017

- Delivering on growth ambitions with good Q1 2017 performance: o Net sales $307.7 million (+3% actual); adjusted net sales $308.3...


May 02, 2017, 02:00 ET QIAGEN Partners With Maccura to Localize and Commercialize GeneReader NGS System in China

Partnership with a leading Chinese IVD company with goal to accelerate penetration of the world's first complete Sample to Insight NGS solution in...


Apr 12, 2017, 16:05 ET New Research Suggests Potential for Additional Clinical Utility of QIAGEN's QuantiFERON-TB Gold Plus

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that two peer-reviewed studies indicate the potential additional...


Apr 06, 2017, 12:15 ET QIAGEN Posts 2016 Annual Report on its Website

QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) has posted its 2016 Annual Report on its website at...


Apr 06, 2017, 09:15 ET QIAGEN N.V. to Report First Quarter 2017 Results

QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans to release its report on results for the first quarter of 2017 on Tuesday, May 2, at...